Literature DB >> 16112482

Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease.

U B Schambra1, G B Mackensen, M Stafford-Smith, D E Haines, D A Schwinn.   

Abstract

Recent data suggest novel functional roles for cerebellar involvement in a number of neurologic diseases. Function of cerebellar neurons is known to be modulated by norepinephrine and adrenergic receptors. The distribution of adrenergic receptor subtypes has been described in experimental animals, but corroboration of such studies in the human cerebellum, necessary for drug treatment, is still lacking. In the present work we studied cell-specific localizations of alpha1 adrenergic receptor subtype mRNA (alpha 1a, alpha 1b, alpha 1d), and alpha2 adrenergic receptor subtype mRNA (alpha 2a, alpha 2b, alpha 2c) by in situ hybridization on cryostat sections of human cerebellum (cortical layers and dentate nucleus). We observed unique neuron-specific alpha1 adrenergic receptor and alpha2 adrenergic receptor subtype distribution in human cerebellum. The cerebellar cortex expresses mRNA encoding all six alpha adrenergic receptor subtypes, whereas dentate nucleus neurons express all subtype mRNAs, except alpha 2a adrenergic receptor mRNA. All Purkinje cells label strongly for alpha 2a and alpha 2b adrenergic receptor mRNA. Additionally, Purkinje cells of the anterior lobe vermis (lobules I to V) and uvula/tonsil (lobules IX/HIX) express alpha 1a and alpha 2c subtypes, and Purkinje cells in the ansiform lobule (lobule HVII) and uvula/tonsil express alpha 1b and alpha 2c adrenergic receptor subtypes. Basket cells show a strong signal for alpha 1a, moderate signal for alpha 2a and light label for alpha 2b adrenergic receptor mRNA. In stellate cells, besides a strong label of alpha 2a adrenergic receptor mRNA in all and moderate label of alpha 2b message in select stellate cells, the inner stellate cells are also moderately positive for alpha 1b adrenergic receptor mRNA. Granule and Golgi cells express high levels of alpha 2a and alpha 2b adrenergic receptor mRNAs. These data contribute new information regarding specific location of adrenergic receptor subtypes in human cerebellar neurons. We discuss our observations in terms of possible modulatory roles of adrenergic receptor subtypes in cerebellar neurons responding to sensory and autonomic input signals, and review species differences in cerebellar adrenergic receptor expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112482      PMCID: PMC2277099          DOI: 10.1016/j.neuroscience.2005.06.021

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  130 in total

1.  Cloning, characterisation and identification of several polymorphisms in the promoter region of the human alpha2B-adrenergic receptor gene.

Authors:  Cécile Cayla; Paula Heinonen; Liisa Viikari; Stéphane Schaak; Amir Snapir; Anne Bouloumié; Matti K Karvonen; Ullamari Pesonen; Mika Scheinin; Hervé Paris
Journal:  Biochem Pharmacol       Date:  2004-02-01       Impact factor: 5.858

Review 2.  The cerebellar norepinephrine system: inhibition, modulation, and gating.

Authors:  D J Woodward; H C Moises; B D Waterhouse; H H Yeh; J E Cheun
Journal:  Prog Brain Res       Date:  1991       Impact factor: 2.453

Review 3.  An emerging concept. The cerebellar contribution to higher function.

Authors:  J D Schmahmann
Journal:  Arch Neurol       Date:  1991-11

4.  Localization of alpha 2A- and alpha 2B-adrenergic receptor subtypes in brain.

Authors:  A Tavares; D E Handy; N N Bogdanova; D L Rosene; H Gavras
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

5.  Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study.

Authors:  P C Berquin; J N Giedd; L K Jacobsen; S D Hamburger; A L Krain; J L Rapoport; F X Castellanos
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

6.  Beta-adrenergic enhancement of inhibitory synaptic activity in rat cerebellar stellate and Purkinje cells.

Authors:  I Llano; H M Gerschenfeld
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

7.  Ultrastructural analysis of catecholaminergic innervation in weaver and normal mouse cerebellar cortices.

Authors:  L C Abbott; C Sotelo
Journal:  J Comp Neurol       Date:  2000-10-16       Impact factor: 3.215

8.  Catecholamines in mutant mouse cerebellum: fluorescence microscopic and chemical studies.

Authors:  S C Landis; W J Shoemaker; M Schlumpf; F E Bloom
Journal:  Brain Res       Date:  1975-08-08       Impact factor: 3.252

9.  Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy.

Authors:  S J Kish; K S Shannak; O Hornykiewicz
Journal:  J Neurochem       Date:  1984-05       Impact factor: 5.372

10.  Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system.

Authors:  E M Talley; D L Rosin; A Lee; P G Guyenet; K R Lynch
Journal:  J Comp Neurol       Date:  1996-08-12       Impact factor: 3.215

View more
  14 in total

Review 1.  Models of calcium dynamics in cerebellar granule cells.

Authors:  Elena È Saftenku
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

2.  The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells.

Authors:  Maria I Wenner; Garth L Maker; Linda F Dawson; Peter D Drummond; Ian Mullaney
Journal:  Cytotechnology       Date:  2015-09-25       Impact factor: 2.058

Review 3.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

4.  Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i.

Authors:  Leif Hertz; Ditte Lovatt; Steven A Goldman; Maiken Nedergaard
Journal:  Neurochem Int       Date:  2010-04-07       Impact factor: 3.921

5.  Pontine and cerebellar norepinephrine content in adult rats recovering from focal cortical injury.

Authors:  Rigoberto Gonzalez-Pina; Antonio Bueno-Nava; Sergio Montes; Alfonso Alfaro-Rodriguez; Angelica Gonzalez-Maciel; Rafael Reynoso-Robles; Fructuoso Ayala-Guerrero
Journal:  Neurochem Res       Date:  2006-11-09       Impact factor: 3.996

6.  Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons.

Authors:  B Li; T Du; H Li; L Gu; H Zhang; J Huang; L Hertz; L Peng
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

7.  Secretin's role in the cerebellum: a larger biological context and implications for developmental disorders.

Authors:  Martha G Welch; Robert J Ludwig; Mark Opler; David A Ruggiero
Journal:  Cerebellum       Date:  2006       Impact factor: 3.648

8.  The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients.

Authors:  Jingyu Liu; Peter Siyahhan Julnes; Jiayu Chen; Stefan Ehrlich; Esther Walton; Vince D Calhoun
Journal:  Schizophr Res       Date:  2015-09-14       Impact factor: 4.939

9.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

Review 10.  Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.

Authors:  P R Bharadwaj; K A Bates; T Porter; E Teimouri; G Perry; J W Steele; S Gandy; D Groth; R N Martins; Giuseppe Verdile
Journal:  Transl Psychiatry       Date:  2013-12-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.